Login or sign up
For business

Tarveda Therapeutics

4.1ยท 12 reviews
Average ratingGreat
4.1/ 5

Based on 12 reviews

542%
425%
333%
20%
10%
Ask AI

Questions about Tarveda Therapeutics

Based on 12 reviews, listing data and website checks ยท updated 4 days ago

What is Tarveda Therapeutics?

Tarveda Therapeutics develops miniature drug conjugates for treating patients with solid tumors. Their lead drug candidate, PEN-866, is a HSP90 targeted drug conjugate that selectively binds to activated Heat Shock Protein 90 in tumors. The company also has a miniature drug conjugate in clinical evaluation for patients with somatostatin receptor 2 (SSTR2) expressing neuroendocrine, small cell lung, and other solid tumors.

What specific technology or platform does Tarveda Therapeutics use?

The company's website states that their platform enables companies to extend the lives of patients with hard-to-treat cancers while minimizing potential toxicities. Their HSP90 targeted drug conjugate releases a potent topoisomerase 1 inhibitor payload, SN38, specifically within tumor environments.

How recent and how many reviews are on the Trustburn listing?

The Trustburn listing shows a rating of 4.1 out of 5 stars based on 12 reviews. The most recent review was posted on November 28, 2023, and the oldest review in the list is from March 1, 2023.

What do reviewers praise about Tarveda Therapeutics?

Reviewers consistently praise the team for being highly responsive, knowledgeable, and helpful. Many users also note that the website is easy to navigate, user-friendly, and provides comprehensive information about the company's services.

What do reviewers complain about?

All 12 reviews on Trustburn are positive, with ratings ranging from 3 to 5 stars. No negative complaints or specific grievances were mentioned in the provided review text.

What detail from the business's own website is highlighted by reviewers?

The company's website, tarvedatx.com, is described by reviewers as intuitive, well-designed, and informative. It contains all the necessary information and is easy to use for visitors seeking details about their products.

How can I contact Tarveda Therapeutics?

You can reach Tarveda Therapeutics by e-mail at info@tarveda.com.

AI-generated from reviews on this page. Verify anything important with the company directly.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website โ€” a simple way to convert your visitors into customers.

Get the widget for your site →

About Tarveda Therapeutics

Tarveda Therapeutics is a developer of miniature drug conjugates designed for the treatment of patients with a wide range of solid tumors. The company's HSP90 targeted drug conjugate platform with lead drug candidate PEN-866 selectively binds in tumors to the activated form of Heat Shock Protein 90 (HSP90) and releases its potent topoisomerase 1 inhibitor payload, SN38 and it also develops a miniature drug conjugate in clinical evaluation for the treatment of patients with somatostatin receptor 2 (SSTR2) expressing neuroendocrine, small cell lung and other solid tumors, enabling companies to extend the lives of patients with hard to treat cancers while minimizing potential toxicities.